BioCentury
ARTICLE | Clinical News

CY-1899: Began Phase I trial

October 11, 1993 7:00 AM UTC

Cytel Corp. (CYTL) Product: CY-1899 immunotherapeutic vaccine Indication: Hepatitis B Status: Began Phase I trial ...